Cabot Corporation
CBTNYSEBasic Materials● Active
$81.91
+$1.03(+1.27%)
Market Cap$4.2B
P/E Ratio—
52W High$89.46
52W Low$58.33
Cabot Corporation (CBT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$1.61
Est. $1.47 · +9.5%
Revenue
$0.90B
Est. $0.90B · +0.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS🔥 6-Quarter EPS Beat Streak
CBT reports quarterly as a NYSE-listed Chemicals - Specialty company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $1.66 | — | — | — | $0.93B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $1.47 | $1.61 | +9.5% | $0.90B | $0.90B | +0.4% |
| ▲ Q1 FY2026 | Feb 3, 2026 | $1.40 | $1.53 | +9.3% | $0.85B | $0.89B | -4.3% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $1.68 | $1.70 | +1.2% | $0.90B | $0.93B | -3.3% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $1.82 | $1.90 | +4.4% | $0.92B | $0.98B | -5.6% |
| ▲ Q2 FY2025 | May 5, 2025 | $1.85 | $1.90 | +2.7% | $0.94B | $0.95B | -2.0% |
| ▲ Q1 FY2025 | Feb 3, 2025 | $1.74 | $1.76 | +1.1% | $0.95B | $1.03B | -6.9% |
| ▼ Q4 FY2024 | Nov 4, 2024 | $1.82 | $1.80 | -1.1% | $1.00B | $1.01B | -0.9% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$1.66
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$1.61
EPS Est.
$1.47
EPS Surpr.
+9.5%
Revenue
$0.90B
Q1 FY2026
Feb 3, 2026Beat
EPS Actual
$1.53
EPS Est.
$1.40
EPS Surpr.
+9.3%
Revenue
$0.85B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$1.70
EPS Est.
$1.68
EPS Surpr.
+1.2%
Revenue
$0.90B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$1.90
EPS Est.
$1.82
EPS Surpr.
+4.4%
Revenue
$0.92B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$1.90
EPS Est.
$1.85
EPS Surpr.
+2.7%
Revenue
$0.94B
Q1 FY2025
Feb 3, 2025Beat
EPS Actual
$1.76
EPS Est.
$1.74
EPS Surpr.
+1.1%
Revenue
$0.95B
Q4 FY2024
Nov 4, 2024Miss
EPS Actual
$1.80
EPS Est.
$1.82
EPS Surpr.
-1.1%
Revenue
$1.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $1.93 | $1.98 | $2.03 | 1 |
| Q2 FY2028 | $2.00 | $2.05 | $2.09 | 1 |
| Q1 FY2028 | $1.89 | $1.94 | $1.98 | 1 |
| Q4 FY2027 | $1.69 | $1.73 | $1.77 | 1 |
| Q3 FY2027 | $1.79 | $1.84 | $1.88 | 1 |
| Q2 FY2027 | $1.84 | $1.89 | $1.93 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q2 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q1 FY2028 | $1.0B | $1.0B | $1.0B | 1 |
| Q4 FY2027 | $0.8B | $0.9B | $0.9B | 1 |
| Q3 FY2027 | $0.9B | $1.0B | $1.0B | 2 |
| Q2 FY2027 | $0.9B | $1.0B | $1.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +9.5% | $75.85 | $78.93 | +4.06% |
| ▲ Q1 FY2026 | Feb 3, 2026 | +9.3% | $72.86 | $71.29 | -2.15% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +1.2% | $67.48 | $65.90 | -2.34% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +4.4% | $72.00 | $73.71 | +2.37% |
| ▲ Q2 FY2025 | May 5, 2025 | +2.7% | $77.99 | $77.50 | -0.63% |
| ▲ Q1 FY2025 | Feb 3, 2025 | +1.1% | $86.47 | $84.87 | -1.85% |
| ▼ Q4 FY2024 | Nov 4, 2024 | -1.1% | $109.02 | $110.09 | +0.98% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +11.6% | $89.91 | $86.96 | -3.28% |
Q2 FY2026+4.06%
Report Date
May 5, 2026
EPS Beat/Miss
+9.5%
Price Before
$75.85
Price After
$78.93
Q1 FY2026-2.15%
Report Date
Feb 3, 2026
EPS Beat/Miss
+9.3%
Price Before
$72.86
Price After
$71.29
Q4 FY2025-2.34%
Report Date
Nov 3, 2025
EPS Beat/Miss
+1.2%
Price Before
$67.48
Price After
$65.90
Q3 FY2025+2.37%
Report Date
Aug 4, 2025
EPS Beat/Miss
+4.4%
Price Before
$72.00
Price After
$73.71
Q2 FY2025-0.63%
Report Date
May 5, 2025
EPS Beat/Miss
+2.7%
Price Before
$77.99
Price After
$77.50
Q1 FY2025-1.85%
Report Date
Feb 3, 2025
EPS Beat/Miss
+1.1%
Price Before
$86.47
Price After
$84.87
Q4 FY2024+0.98%
Report Date
Nov 4, 2024
EPS Beat/Miss
-1.1%
Price Before
$109.02
Price After
$110.09
Q3 FY2024-3.28%
Report Date
Aug 5, 2024
EPS Beat/Miss
+11.6%
Price Before
$89.91
Price After
$86.96
Avg Beat Reaction-0.55%
Avg Miss Reaction+0.98%
Beat Rate7 / 8 quarters
Largest Move+4.06% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBT ends December
Cabot Corporation (CBT) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $1.61 — beating the analyst consensus of $1.47 by +9.5%. CBT has beaten EPS estimates for 6 consecutive quarters. The next CBT earnings date is expected around September 1, 2026.
Each quarter, investors track CBT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBT earnings · 5 questionsCabot Corporation's next earnings report is expected around September 1, 2026. CBT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBT historically reports after market close (AMC).
CBT earnings datewhen is CBT earningsCBT next earnings datewhen does CBT report earningsCBT earnings calendar
▸ Source: FMP · Cabot Corporation SEC filings · US GAAP · Cabot Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026